Off the Shelf: Stoner by John Williams
Dr. David Steensma gives his recommendation of a book that shows there can be value in a life that seems unfulfilled.
Circulating Tumor DNA in Lymphoma Monitoring: Fantasy, Fad, or Fact?
Dr. Kim discusses a study that showcases the utility of circulating tumor DNA monitoring in classic Hodgkin lymphoma.
A number of publications from 2014 that impact our understanding and treatment of multiple myeloma (MM) stand out. First, insights into the mechanism of action of thalidomide and its analogues came fast and frequently. With more direct therapeutic relevance, the results of the Phase III ASPIRE clinical trial were published. This trial tested the hypothesis that three drugs would be better than two in relapsed MM. Finally, a randomized trial reconfirmed the role of transplantation in MM patients younger than 65 years.
July-August 2018Volume 15, Issue 4
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology